In this follow up interview with Dr. Hodkinson, we discuss some of the more peculiar and esoteric aspects of the mRNA injections, including contagious vaccinosis, and the magnetic phenomenon.
We thought the magnetic thing was nonsense personally. But I tested 5 people personally and 4 of them, the magnet stuck to the injection site, and that is with the injectee standing up and in 2 cases, after wiping the upper arm down with alcohol to make sure it wasn’t just sticky skin.
I don’t think my tests would meet James Randi’s standards, but it seemed indicative to me that there is something going on with the Pfizer shots and something magnetic, and it turns out there is solid literature on it. At the very least it would be worthy of new testing with James Randi level scrutiny.
Here is some of the literature on using magnetic nano-particles to make DNA and RNA get into cells more efficiently. This isn’t really new or even leading edge science anymore going by the dates.
Starting with the esoteric, The Guardian, March 2016: Genetically engineered ‘Magneto’ protein remotely controls brain and behaviour
Researchers in the United States have developed a new method for controlling the brain circuits associated with complex animal behaviours, using genetic engineering to create a magnetised protein that activates specific groups of nerve cells from a distance.
Understanding how the brain generates behaviour is one of the ultimate goals of neuroscience – and one of its most difficult questions. In recent years, researchers have developed a number of methods that enable them to remotely control specified groups of neurons and to probe the workings of neuronal circuits.
“From a distance”.
Pubmed, 2014: Superparamagnetic nanoparticle delivery of DNA vaccine
The efficiency of delivery of DNA vaccines is often relatively low compared to protein vaccines. The use of superparamagnetic iron oxide nanoparticles (SPIONs) to deliver genes via magnetofection shows promise in improving the efficiency of gene delivery both in vitro and in vivo. In particular, the duration for gene transfection especially for in vitro application can be significantly reduced by magnetofection compared to the time required to achieve high gene transfection with standard protocols. SPIONs that have been rendered stable in physiological conditions can be used as both therapeutic and diagnostic agents due to their unique magnetic characteristics. Valuable features of iron oxide nanoparticles in bioapplications include a tight control over their size distribution, magnetic properties of these particles, and the ability to carry particular biomolecules to specific targets. The internalization and half-life of the particles within the body depend upon the method of synthesis. Numerous synthesis methods have been used to produce magnetic nanoparticles for bioapplications with different sizes and surface charges.
Delivery of antisense oligodesoxynucleotides (ODN) into primary cells is a specific strategy for research with therapeutic perspectives but transfection-associated difficulties. We established the technique of magnetofection to enhance ODN delivery at low toxicity and procedure time in vitro and in vivo. In vitro, target knockout was assessed at protein and mRNA levels and by measuring superoxide generation after antisense magnetofection against the p22(phox) subunit of endothelial NAD(P)H-oxidase. Under magnetic field guidance, low-dose magnetic particle-bound ODN were transfected to 84% human umbilical vein endothelial cells within 15 min followed by nuclear accumulation within 2 h, which required 24 h using standard methods. Antisense magnetofection against p22(phox) significantly decreased basal and prevented stimulated superoxide release due to loss of NAD(P)H-oxidase activity by mRNA knockout as assessed after 24 h. Knockout of endothelial phosphatase SHP-1 and connexin 37 proteins confirmed the method’s efficiency. Transfection-associated toxicity was minimal. Twenty-four hours after injection of fluorescence-labeled ODN into femoral arteries of male mice, there was specific ODN uptake only into cremaster vessels exposed to magnetic fields during injection. Magnetofection is an ideal tool for delivery of functionally active ODN to difficult-to-transfect cells to study gene/protein function and a promising strategy for targeted ODN delivery in vivo.
Magnetofection™ is a novel, simple and highly efficient method to transfect cells in culture. It exploits magnetic force exerted upon gene vectors associated with magnetic particles to draw the vectors towards, possibly even into, the target cells. In this manner, the full vector dose applied gets concentrated on the cells within a few minutes so that 100% of the cells get in contact with a significant vector dose. This has several important consequences:
- Greatly improved transfection rates in terms of percentage of cells transfected compared to standard transfection.
- Up to several thousand fold increased levels of transgene expression compared to standard transfections upon short-term incubation.
- High transfection rates and transgene expression levels are achievable with extremely low vector doses, which allows to save expensive transfection reagents.
- Extremely short process time. A few minutes of incubation of cells with gene vectors are sufficient to generate high transfection efficiency, compared to several hours with standard procedures.
The following video may be related, or not:
Here is the video above, taken to a nano-level:
Just because I made a couple of James Randi references and many may not know why…
Eeyore for VladTepesBlog